Assessment of drug induced hyperuricemia and gout risk using the FDA adverse event reporting system
Abstract Hyperuricemia, the key pathological basis of gout, is increasingly prevalent worldwide. While lifestyle factors contribute, various medications also play a role. However, their specific risks and mechanisms remain inadequately studied. Disproportionality analysis (ROR, PRR, BCPNN) was used...
Saved in:
| Main Authors: | Guihao Zheng, Meifeng Lu, Yulong Ouyang, Shuilin Chen, Bei Hu, Shuai Xu, Guicai Sun |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-06114-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The gut microbiome: a vital link to hyperuricemia, gout and acute flares?
by: Wei Wang, et al.
Published: (2025-08-01) -
NEW OPPORTUNITIES FOR CORRECTION OF HYPERURICEMIA IN GOUT
by: Svetlana Evgenyevna Myasoedova, et al.
Published: (2009-12-01) -
Mechanisms of cartilage damage in gout and hyperuricemia
by: E. V. Panina
Published: (2024-04-01) -
Transcriptomic Analysis of Peripheral Blood Mononuclear Cells in Hyperuricemia and Gout
by: Valentin NICA, et al.
Published: (2025-05-01) -
Epidemiological perspectives on emerging contaminants and gout or hyperuricemia
by: Weiwen Fu, et al.
Published: (2025-06-01)